Menu

Blog

Archive for the ‘biotech/medical’ category: Page 682

Oct 31, 2022

Engineering students have developed a 3D-printed prosthetic arm for people with disabilities

Posted by in categories: 3D printing, biotech/medical, cyborgs, engineering

More affordable than the regular ones.

The Arm2u biomedical engineering team from the Barcelona School of Industrial Engineering (ETSEIB) of the Universitat Politècnica de Catalunya designed and constructed a configurable transradial prosthesis that responds to the user’s nerve impulses using 3D printing technology.

Arm2u is a prosthesis that can replace a missing arm below the elbow. It can be controlled with myoelectric control, which means that it is controlled by the natural electrical signals produced by muscle contraction.

Continue reading “Engineering students have developed a 3D-printed prosthetic arm for people with disabilities” »

Oct 31, 2022

The patient who got the world’s first pig heart transplant has died after 2 months

Posted by in categories: biotech/medical, genetics

Here is what the ECG reports of the first patient with the pig heart say.

In January this year, the heart of a genetically modified pig was transplanted into a human for the first time. The patient, David Bennett, managed to survive for two months with the pig heart, and this unique organ transplant operation led to various exciting findings and further research work.

One recently published research reveals that the electrical conduction system (network of cells, signals, and nodes in a heart that collectively controls heart functions and heartbeat) of the genetically modified pig heart differs from that of an ordinary pig’s heart.

Continue reading “The patient who got the world’s first pig heart transplant has died after 2 months” »

Oct 31, 2022

Tech billionaires lost nearly half a trillion dollars in 2022

Posted by in category: biotech/medical

Times after the pandemic have not been good for tech giants.

The world’s 20 richest tech billionaires have lost close to half a trillion dollars in 2022 so far. Fears of a recession and increased interest rates have dipped revenues of tech companies in the U.S., and market valuations of their companies have tumbled thereafter, Wall Street Journal.

Mark Zuckerberg might be the poster boy for how falling revenues of tech companies also shrink the personal fortunes of the founders since most of their wealth is associated with stocks of the companies they have founded.

Oct 31, 2022

New Clues Into a Serious Neurodegenerative Disease, Frontotemporal Dementia

Posted by in categories: biotech/medical, genetics, neuroscience

Summary: A genetic form of frontotemporal dementia is associated with abnormal lipid accumulation in the brain fueled by disrupted cell metabolism. The findings could pave the way for new targeted therapies for FTD.

Source: Harvard.

Dementia encompasses a range of neurodegenerative conditions that lead to memory loss and cognitive deficiencies and affect some 55 million people worldwide. Yet despite its prevalence, there are few effective treatments, in part because scientists still don’t understand how exactly dementia arises on a cellular and molecular level.

Oct 31, 2022

Scientists Astonished

Posted by in categories: biotech/medical, business, engineering, law, policy

‘Like conductive Play-Doh’: breakthrough could point way to a new class of materials for electronic devices.

University of Chicago.

Founded in 1,890, the University of Chicago (UChicago, U of C, or Chicago) is a private research university in Chicago, Illinois. Located on a 217-acre campus in Chicago’s Hyde Park neighborhood, near Lake Michigan, the school holds top-ten positions in various national and international rankings. UChicago is also well known for its professional schools: Pritzker School of Medicine, Booth School of Business, Law School, School of Social Service Administration, Harris School of Public Policy Studies, Divinity School and the Graham School of Continuing Liberal and Professional Studies, and Pritzker School of Molecular Engineering.

Oct 31, 2022

Hark back to the late 1990s with this re-creation of the dialup Internet experience

Posted by in categories: biotech/medical, computing, mobile phones

We all found our coping strategies for riding out the pandemic in 2020. Biomedical engineer Gough Lui likes to tinker with tech—particularly vintage tech—and decided he’d try to recreate what it was like to connect to the Internet via dialup back in the late 1990s. He recorded the entire process in agonizing real time, dotted with occasional commentary.

Those of a certain age (ahem) well remember what it used to be like: even just booting up the computer required patience, particularly in the earlier part of the decade, when one could shower and make coffee in the time it took to boot up one’s computer from a floppy disk. One needed a dedicated phone line for the Internet connection, because otherwise an incoming call could disrupt the connection, forcing one to repeat the whole dialup process.

Oct 31, 2022

Biotechnology is creating ethical worries—and we’ve been here before

Posted by in categories: bioengineering, biotech/medical, chemistry, ethics, genetics, health

Matthew Cobb is a zoologist and author whose background is in insect genetics and the history of science. Over the past decade or so, as CRISPR was discovered and applied to genetic remodeling, he started to get concerned—afraid, actually—about three potential applications of the technology. He’s in good company: Jennifer Doudna, who won the Nobel Prize in Chemistry in 2020 for discovering and harnessing CRISPR, is afraid of the same things. So he decided to delve into these topics, and As Gods: A Moral History of the Genetic Age is the result.

Summing up fears

The first of his worries is the notion of introducing heritable mutations into the human genome. He Jianqui did this to three human female embryos in China in 2018, so the three girls with the engineered mutations that they will pass on to their kids (if they’re allowed to have any) are about four now. Their identities are classified for their protection, but presumably their health is being monitored, and the poor girls have probably already been poked and prodded incessantly by every type of medical specialist there is.

Oct 31, 2022

World’s first cloned arctic wolf is now 100 days old

Posted by in categories: biotech/medical, existential risks

Chinese researchers have created the world’s first cloned Arctic wolf — an achievement that could help save other species from extinction and ensure the biodiversity of our planet.

Why it matters: Scottish scientists proved back in 1996 that it was possible to clone a mammal using a cell from an adult animal. Possible — but not easy. Dolly the sheep was the only successful clone in their 277 attempts.

Cloning is still a challenging process — fewer than 25 animal species have been cloned to date, so the first successful cloning of a species is still newsworthy 25+ years after Dolly’s birth.

Oct 31, 2022

Cedars-Sinai Awarded $8 Million to Launch New Stem Cell Clinic

Posted by in categories: biotech/medical, life extension

Newswise — LOS ANGELES (Oct. 28, 2022) — Cedars-Sinai has been awarded a five-year, $8 million grant from California’s stem cell agency to launch an innovative new clinic that will expand patients’ access to stem cell and gene therapies, increase research and training in regenerative medicine, foster greater collaboration with eight similar clinics across the state and help educate the public about stem cell and related therapies.

The California Institute for Regenerative Medicine (CIRM) approved Cedars-Sinai’s plan to establish an Alpha Stem Cell Clinic, bringing Cedars-Sinai into a network of Alpha sites throughout California. The Cedars-Sinai clinic will develop preclinical studies into early and later phase clinical trials with the goal of establishing advanced regenerative medicine treatments that are FDA-approved for patients with debilitating diseases.

The Cedars-Sinai initiative is being led by the Cedars-Sinai Board of Governors Regenerative Medicine Institute and the Smidt Heart Institute. They are modeling the new Alpha Clinic on a jointly run Regenerative Medicine Clinic established at Cedars-Sinai in 2014—expanding scientific discovery and clinical trials for neurological, cardiovascular, musculoskeletal and autoimmune diseases.

Oct 31, 2022

Rapamycin is the most promising aging intervention we currently have

Posted by in categories: biotech/medical, life extension

It was in 1975 when scientists from Ayerst (now Pfizer) discovered a novel compound called rapamycin (also known as Sirolimus) in bacteria on Rapa Nui(Easter Island) in Chile. In 1999 rapamycin obtained FDA approval for the prevention of acute rejection of renal transplant. Unknown at the time, rapamycin would become the most potent anti-aging drug that humans currently hold.

This is the first article of a two-part series on rapamycin.

The profound effect rapamycin has on lifespan was first observed in yeast cells, and later confirmed in every model organism tested, including the nematode C. elegans, fruit flies, and mice.

Page 682 of 2,560First679680681682683684685686Last